Similar articles

• High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer: yes.

  Peters WP. Peters WP. Important Adv Oncol. 1995:215-30. Important Adv Oncol. 1995. PMID: 7672808 Review. No abstract available.
• High-dose therapy in breast cancer: out of favor but not out of promise.

  Glück S, Stewart D. Glück S, et al. Bone Marrow Transplant. 2000 May;25(10):1017-9. doi: 10.1038/sj.bmt.1702388. Bone Marrow Transplant. 2000. PMID: 10828859
• High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.

  Smith GA, Henderson IC. Smith GA, et al. Important Adv Oncol. 1995:201-14. Important Adv Oncol. 1995. PMID: 7672807 Review. No abstract available.
• Dose intensification using combination alkylating agents and autologous bone marrow support in the treatment of primary and metastatic breast cancer: a review of the Duke Bone Marrow Transplantation Program experience.

  Peters WP. Peters WP. Prog Clin Biol Res. 1990;354B:185-94. Prog Clin Biol Res. 1990. PMID: 2236164 Review. No abstract available.
• [High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy in primary breast cancer. An analysis of a systematic Cochrane review].

  Nielsen DL, Svane IM. Nielsen DL, et al. Ugeskr Laeger. 2004 Nov 8;166(46):4148-50. Ugeskr Laeger. 2004. PMID: 15565849 Danish. No abstract available.